Announcements Trials
Browse Landscape

Phase

Phase 3 1

Status

Active not recruiting 1

Sponsor Class

NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Hepatoblastoma 5Colorectal Neoplasms 2Colonic Neoplasms 2Wilms Tumor 1Sarcoma, Ewing 1Rhabdomyosarcoma 1Rectal Neoplasms 1PRETEXT I Hepatoblastoma 1Neuroblastoma 1Neoplasms 1Fibrolamellar hepatocellular carcinoma 1Carcinoma, Hepatocellular 1

Interventions

Nivolumab 3Ipilimumab 3poly ICLC 2Specimen Handling 2Sorafenib 2Irinotecan 2Cyclophosphamide 2spartalizumab 1sapanisertib 1pembrolizumab 1fludarabine 1durvalumab 1dostarlimab 1dehydroftorafur 1balstilimab 1atezolizumab 1aflibercept 1Whole-Body Irradiation 1Watchful Waiting 1Vincristine 1Tacrolimus 1Surveys and Questionnaires 1Sunitinib 1Prednisone 1Platinum 1Oxaliplatin 1Observation 1Mycophenolic Acid 1Mesna 1Leuprolide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Fibrolamellar hepatocellular carcinoma × Vincristine × Gastrointestinal × Clear all
NCT03533582 2025-12-22

Cisplatin and Combination Chemotherapy in Treating Children and Young Adults With Hepatoblastoma or Liver Cancer After Surgery

Children's Oncology Group

Phase 3 Active not recruiting
537 enrolled
Gastrointestinal

Fibrolamellar hepatocellular carcinoma, Hepatoblastoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡